Phoenix Pharma
Maren Holoda has a diverse work experience. Maren started their career as an intern at Friedrich Naumann Foundation in 2004. In 2008, they worked as a Consultant at Eurostaff - Connecting Europe™. Then, they joined GIRP - The European Association of Pharmaceutical Full-line Wholesalers, where they held the positions of Information and Research Manager from May 2008 to June 2010, and European Corporate Affairs Manager from June 2010 to February 2013. Maren then worked for Brocacef as a Medewerker Marketing & Communicatie from September 2012 to May 2013, and as a Directie Adviseur from May 2013 to March 2014. Currently, they work at PHOENIX group - Integrated Healthcare Provider, where they started as a Strategic Assistant to the Executive Board Member Operations/Logistics in March 2014. Maren then held various roles, including Head of Corporate Sales & Marketing Network from September 2018 to June 2020, Head of Corporate Communications from June 2020 to September 2020, and currently holds the position of Director Corporate Communications since September 2020.
Maren Holoda has a diverse educational background. In 2002, they enrolled at the University of Warwick and pursued a Bachelor of Arts (B.A.) degree in Politics with International Studies. Maren successfully completed their undergraduate program in 2006. In the same year, Maren attended UCL and obtained a Master of Science (M.Sc.) degree in International Public Policy. Their studies at UCL lasted until 2007, helping their gain further knowledge and expertise in their field. Additionally, in 2004 and 2005, they also attended Sciences Po, where they received a Diplôme du Programme International du 1er Cycle. However, the field of study for this particular program is not specified.
This person is not in any offices
Phoenix Pharma
2 followers
PHOENIX Pharmahandel Aktiengesellschaft & Co KG (PHOENIX Group), headquartered in Mannheim, Baden-Württemberg is the largest pharmaceutical wholesaler in Germany, and the second largest in Europe with about 20 distribution centers across the country delivering drugs to some 12,000 independent pharmacies. Its PHOENIX Documentation is an Internet-based archive offering detailed information on drugs, their components, indications, and effects. Formation of Holding company PHOENIX International Beteiligungs GmbH. Phoenix Group is majority owner of the pharmaceutical wholesalers Purus A.S. in the Czech Republic and Tamro in Finland. Phoenix Group itself is majority-owned by pharmaceutical conglomerate Merckle Group.